| Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce today that on Friday November 11, 2011, Positron and Manhattan Isotope Technology LLC. (MIT LLC) entered into a binding Letter of Intent to acquire MIT LLC. The transaction will close January 2, 2012 upon execution of final transaction documents. Manhattan Isotope is the leading commercial resource in the United States with practical knowledge and experience in...continued POSC imaging mri perfusion |
Monday, November 14, 2011
Positron Agrees to Acquire Manhattan Isotope Technology LLC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment